Skip to content

Clinical trials

Burkitt Lymphoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Country / region: France Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20043
20052
20072
20081
20101
20111
20121
20141
20151
20165
20171
20181
20194
20223
20233
20241
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting8
Terminated6
Unknown status4
Active, not recruiting3
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC6
Novartis Pharmaceuticals4
Gustave Roussy, Cancer Campus, Grand Paris3
Amgen Research (Munich) GmbH2
Assistance Publique - Hôpitaux de Paris2
Children's Oncology Group2
Institut Paoli-Calmettes2
Institut de Recherches Internationales Servier2
Merck Sharp & Dohme LLC2
Assistance Publique Hopitaux De Marseille1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma41
Precursor Cell Lymphoblastic Leukemia-Lymphoma18
Lymphoma, Non-Hodgkin17
Lymphoma, Large B-Cell, Diffuse16
Lymphoma, Follicular15
Leukemia13
Leukemia, Lymphocytic, Chronic, B-Cell13
Lymphoma, B-Cell, Marginal Zone13
Lymphoma, Mantle-Cell13
Hodgkin Disease11

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.